Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term myeloid-leukemia. Found 6 abstracts

Hurria A, Browner IS, Cohen HJ, Denlinger CS, deShazo M, Extermann M, Ganti AK, Holland JC, Holmes HM, Karlekar MB, Keating NL, McKoy J, Medeiros BC, Mrozek E, O'Connor T, Petersdorf SH, Rugo HS, Silliman RA, Tew WP, Walter LC, Weir AB, Wildes T. Senior Adult Oncology. Journal of the National Comprehensive Cancer Network. 2012 Feb;10(2):162-209.   PMCID: not NIH funded
Blay JY, von Mehren M. Nilotinib: A Novel, Selective Tyrosine Kinase Inhibitor. Seminars in Oncology. 2011 Apr;38(2):S3-S9.   PMCID: not NIH funded
Yu EY, Wilding G, Posadas E, Gross M, Culine S, Massard C, Morris MJ, Hudes G, Calabro F, Cheng ST, Trudel GC, Paliwal P, Sternberg CN. Phase II Study of Dasatinib in Patients with Metastatic Castration-Resistant Prostate Cancer. Clinical Cancer Research. 2009 Dec;15(23):7421-8.   PMCID: PMC 3394097
Bono P, Krause A, von Mehren M, Heinrich MC, Blanke CD, Dimitrijevic S, Demetri GD, Joensuu H. Serum KIT and KIT ligand levels in patients with gastrointestinal stromal tumors treated with imatinib. Blood. 2004 Apr;103(8):2929-35.
Dexter DW, Reddy RK, Geles KG, Bansal S, Myint MA, Rogakto A, Leighton JC, Goldstein LJ. Quantitative reverse transcriptase-polymerase chain reaction measured expression of MDR1 and MRP in primary breast carcinoma. Clinical Cancer Research. 1998 Jun;4(6):1533-42.
Petermann R, Mossier BM, Aryee DN, Khazak V, Golemis EA, Kovar H. Oncogenic EWS-Fli1 interacts with hsRPB7, a subunit of human RNA polymerase II. Oncogene. 1998 Aug 06;17(5):603-10.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term myeloid-leukemia

myeloid-leukemia tyrosine kinase expression acute imatinib-resistant chronic c-kit domain lines mini-nutritional assessment binding protein two-hybrid-system 1987 arlson me-journal of chronic diseases-v40-p373 2008 mmcdevitt j-oncology-v22-p1060 overexpression multidrug-resistance malignant-melanoma 1984 lman rs-journal of clinical oncology-v2-p1404 giant-cell tumor resistance-associated protein responses amn107 nilotinib gene acute lymphoblastic-leukemia quality-of-life 2008 pa m-j clin oncol s15-v26 transformation prednisone plus thalidomide chromosome-translocation metastatic colorectal-cancer 1992 ristman k-jama-journal of the american medical association-v268-p57 elderly 2008 mmcdevitt j-oncology-v22-p1058 activation cell lung-cancer ews non-hodgkins-lymphoma myxoid liposarcoma stem-cell factor mutation messenger-rna older patient comprehensive geriatric assessment p-glycoprotein expression transcription factor-tfiib NCCN Guidelines assessment cell-lung-cancer transcription senior adult zoledronic acid mitoxantrone plus prednisone solid src family kinases receptor transporter cytogenetic mesylate chronic myelogenous leukemia bone metastases inappropriate medication use ewings-sarcoma translocation 2009 cleary naj-j clin oncol-v27-p4010 gene- endothelial growth-factor sigma factors colony-stimulating factor tumors soluble kit 1993 eilly se-journal of clinical oncology-v11-p2250 comprehensive geriatric bcr-abl dna-binding ewing tumors in-vitro activity NCCN Clinical Practice Guidelines cancer-patients gastrointestinal stromal tumors advanced age 1994 eson bd-journal of clinical oncology-v12-p2216 cancer treatment
Last updated on Friday, January 03, 2020